Tech Company M&A Transactions
Incline Therapeutics Acquisition
On 12/13/2012, Incline Therapeutics was purchased by The Medicines Company. The acquisition price was $185 million.
Transaction Overview
Company Name
Acquired By
Announced On
12/13/2012
Transaction Type
M&A
Amount
$185,000,000
M&A Terms
The Medicines Company has agreed to pay Incline $185 million in anupfront payment with additional payments if certain regulatory andcommercial milestones are met.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
900 Saginaw Dr. 200
Redwood City, CA 94063
USA
Redwood City, CA 94063
USA
Phone
Website
Email Address
Overview
Incline Therapeutics is a hospital-focused specialty pharmaceutical company focused on the development of IONSYS (fentanyl iontophoretic transdermal system). Incline is financed by leading life science venture capital firms and led by a management team with significant pharmaceutical and medical device industry experience.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alan Levy
Chief Operating Officer
David Socks
Chief Scientific Officer
Brad Phipps
President
David Socks
VP - Engineering
John Lemke
VP - Manufacturing
Mike Ramsay
VP - Product Management
Nitin Joshi
VP - Regulatory Affairs
Patti Oto
Browse more venture capital transactions:
Prev: 12/13/2012: ZetaRx Biosciences venture capital transaction
Next: 12/13/2012: CloudVelox venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs